---
title: "Quince Therapeutics, Inc. (QNCX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/QNCX.US.md"
symbol: "QNCX.US"
name: "Quince Therapeutics, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T18:19:15.023Z"
locales:
  - [en](https://longbridge.com/en/quote/QNCX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/QNCX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/QNCX.US.md)
---

# Quince Therapeutics, Inc. (QNCX.US)

## Company Overview

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient’s own red blood cells, as well as consist of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [quincetx.com](https://quincetx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.53 | 140 | - | - | - |
| PB | 1.11 | 104 | 112.52 | 7.37 | 4.18 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-06T04:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 3 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.08 |
| Highest Target | 10.00 |
| Lowest Target | 5.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/QNCX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/QNCX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/QNCX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/QNCX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**